fuels workshop case study #1...-early adopters wishing to help create a market for reduced ghg...
TRANSCRIPT
© S
tephan G
ladie
u - T
ota
l
FUELS WORKSHOP CASE STUDY #1:
DEVELOPING AND
COMMERCIALIZING
RENEWABLE BIO-JET FUEL
Vineet Rajgarhia
VP Biotechnology R&D
Total New Energies, USA
AGENDA
A little on Total, SA and Total New Energies
The Energy mix expected to meet the need
of the world in 2035 and GHG challenges
Total’s commitment to better energy and our
choice of Solar and Biotechnology
Our partnership with Amyris and Renewable
Bio-Jet Fuel
Development of Farnesane as a renewable
jet fuel
o Jet Fuel
o Certification Process
o Challenges of Developing competitor to
fossil jet fuel
o Current Status
o Future outlook
2 Commercializing Industrial Biotech_Sept. 2015
LNG carrier
Offshore platform
Liquefaction plant
Onshore facility
Oil tanker
Refinery
Specialty chemicals
Petrochemical complex
Oil depot
Service station
Solar panels
Lubricant blending unit
Exploration & Production and Gas & Power
Refining & Chemicals and Trading & Shipping
Marketing & Services and New Energies
NEW ENERGIES IN OUR GLOBAL
AND DIVERSE OPERATION
3 Commercializing Industrial Biotech_Sept. 2015
A Total Primer Upstream Refining & Chemicals Marketing & Services
OUR KEY INDICATORS IN 2014
4
MORE THAN 700 PRODUCTION
FACILITIES
$12.8 bn*
ADJUSTED
NET INCOME
* €9.7bn
$7.39 bn
ALLOCATED
TO R&D
between 2015
and 2019
$236.1 bn*
REVENUE
* €177.7bn
$26.4 bn*
ORGANIC
INVESTMENT
* €19.9bn
EMPLOYEES
100,307
* Employees on the payroll
as of Dec. 31, 2014
Commercializing Industrial Biotech_Sept. 2015
A Total Primer Upstream Refining & Chemicals Marketing & Services
OUTLOOK FOR ENERGY DEMAND
5
+ =
2010
2035
POPULATION GROWTH billion people
ECONOMIC GROWTH $ trillion in 2011
(GDP in purchasing power parity)
HIGHER ENERGY DEMAND million barrels of oil equivalent per day
7 75.2 265
8.5 175.7 349
Sources: UN, IMF, Total, IEA - January 2013
Commercializing Industrial Biotech_Sept. 2015
OUR VISION OF GLOBAL ENERGY DEMAND IN 2035
6
32%
22%
27%
6% 10% 2%
1%
2010 28%
25%
21%
6%
11% 3% 6%
2035
Oil Natural Gas Coal Nuclear Biomass Hydro Solar, wind, other
• Fossil based energies still represent 74% of energy supply in 2035
• Gas to become the second largest energy source before 2030
• Very strong growth of new energies, in particular of solar energy and biomass
Commercializing Industrial Biotech_Sept. 2015
TOTAL’S COMMITMENT TO BETTER ENERGY
Commercializing Industrial Biotech_Sept. 2015 7
25
30
35
40
2005 2010 2015 2020 2025 2030
IEA 450 Scenario
IEA Current Policies Scenario
3.8 Gt
13.8 Gt
Under the IEA 450ppm scenario renewable energy is the 2nd most important way to reduce CO2. Maintaining “status quo” (redline in graph) inadvisable option
Source : International Energy Agency (IEA) World Energy Outlook 2010
17%
9%
24%
50%
Energy Efficiency
Renewable & Biofuel
Nuclear
Carbon Capture and Storage (CCS)
Global Climate Change - CO2 emissions (Gt)
TOTAL’S COMMITMENT TO BETTER ENERGY:
TWEAKING INTERNAL OPERATIONS AND VIA INNOVATION
Successful
Miaden Flights
for Biojet Fuel Flagship Solar
Projects in the
United States
Christophe de Margerie,
Our late Chairman & CEO,
Total
*CSR = corporate and
social responsibility
8 Commercializing Industrial Biotech_Sept. 2015
THE VISION CONTINUES WITH NEW TOTAL
LEADERSHIP
9 Commercializing Industrial Biotech_Sept. 2015
COMMITMENT TO BETTER ENERGY VIA INNOVATION
10
A leader in solar power
• Be a global leader -
SunPower, >66% ownership
• Technological leadership
in solar through cutting-edge
R&D
and manufacturing
excellence
• Be present across the
photovoltaic value chain
Leadership in solar energy and biotechnologies
to address Total’s energy & chemical markets
Produce bio-molecules for Total markets
Differentiate through
technology development –
accelerate innovation via
partnership model
Use Total’s existing capex
infrastructure – find
synergies in Total markets
With an environmentally and
socially sustainable approach
10 Commercializing Industrial Biotech_Sept. 2015
VISION: FROM CO2 TO PRODUCTS
● Back in 2010, strategic decision to focus on plant-to-sugar-to-commodities:
- Step 1 - Hydrocarbons from sugars
- Step 2 - Lignocellulose to access to non food/feed and inexpensive sugars
TOTAL opted for an open-innovation model and has established a collaborative
network in each segment of the value chain
Lipids,
Oils Novogy
Gevo, TWB
Alcools
11 Commercializing Industrial Biotech_Sept. 2015
TOTAL-AMYRIS PARTNERSHIP SINCE JUNE 2010
● Develop the whole value chain integrated from biomass to finished products
Biomass Fermentable
raw materials
Molecules
CiHj
Products
Downstream
Processing Fermentation Pre-treatment
Bio-engineering of
micro-organisms
R&D network
Synthetic biology
1st generation in
Brazil on sugar cane
Leading to 2nd
generation
Feedstock sourcing
Track record for
strain improvement
Scale-up and
industrial chemistry
Fermentation and chemical processes
Fuels Special fluids
Lubricants Chemicals
Competitive
molecules
Access to markets
Trading & marketing
● Strategic alignment: Total has major ownership of Amyris capital
The development of a renewable bio-jet fuel was the first joint program
12 Commercializing Industrial Biotech_Sept. 2015
RENEWABLE JET FUEL OPPORTUNITY
13 Commercializing Industrial Biotech_Sept. 2015
WHAT IS A JET FUEL?
● Most widely used jet fuel: Jet A /
A-1 for commercial civil aviation
- Defined and specified in ASTM
Standard D1655
- Complex mixture of hydrocarbons
and varies depending on crude
source
- Performance specification rather than
a compositional specification.
- Largely relied on accumulated
experience
- kerosene cut between lighter
gasoline and heavier diesel cuts
Jet A / A-1 is a distribution of C8 to C16 hydrocarbons
Source : Edwards 2001,
Briker 2001 and Bacha 2001
14 Commercializing Industrial Biotech_Sept. 2015
KEY SPECIFICATIONS OF JET FUEL
● 21 performances and properties must be met
● This allows a strict control on the quality
- Flash point (prevention of explosions in fuel handling and tanks)
- Energy content (aircraft range)
- Freeze point (ability to pump fuel at low temperature)
- Thermal stability (prevention of fuel system / nozzles clogging or fouling)
- Viscosity (ability to spray fuel and to relight at high altitude)
- Lubricity (ability to lubricates fuel system / engine control)
- Combustion (prevention of particles formation)
- Material compatibility (prevention of the degradation of metals, polymers
and elastomers the fuel is in contact with)
Jet A / A-1 is controlled by feedstocks, processes and properties that guarantee
safe and satisfactory operations of aircraft and engines
15 Commercializing Industrial Biotech_Sept. 2015
JET FUEL MARKET: STEADY GROWTH FOR THE NEXT 15
YEARS
Demand for air transport will grow x2 in the next 15 years, driven by Asia
Steady growth rate of +1.6%/year
Source : Passengers World Traffic (ICAO 2013)
North America 29 %
Latin America
5%
Europe 21%
Middle East 6%
Pacific Asia 30%
RoW (FSU+Africa)
4%
Russia 5%
16 Commercializing Industrial Biotech_Sept. 2015
CHALLENGES TO DEVELOPING AND
COMMERCIALIZING RENEWABLE JET FUEL
17 Commercializing Industrial Biotech_Sept. 2015
FOUR CONSTRAINTS TO COMMERCIALIZE RENEWABLE
JET FUEL
● Safety: renewable jet fuel has to be innocuous to aircraft operations
- Performances similar, or better, to fossil jet fuel in extreme environment
- Compatibility with tanks, engine, engine and fuel systems
● Endurance: yesterday and tomorrow aircrafts operate on the same fuel
- Life span of an aircraft (therefore the engines) is 40 to 50 years
● Drop-in: handling, supply and blending of alternative jet fuel should be
undistinguishable from jet fuel
● Price: renewable jet fuel has to be cost competitive with fossil jet fuel
- Jet fuels costs correspond to 30 - 55% of airlines’ operating costs
Airlines, engine and aircraft OEMs* and jet fuel suppliers prefer a renewable,
sustainable and drop-in jet fuel available in commercial quantities
*OEMs: Original Equipment Manufacturers
18 Commercializing Industrial Biotech_Sept. 2015
19
CURRENT STATUS FOR COMMERCIALIZATION: PRODUCTION
PROCESS AT SCALE, R&D ON-GOING
● Fermentation
- Microbe-catalyzed conversion of sugar: key is the
development of a farnesene producing yeast
- Amyris farnesene plant with a capacity of up to 50 million
liters per year at target efficiency in Brotas, Brazil
- Fermentation process demonstrated on three continents:
Europe, North America and South America
● Downstream Processing
- Combination of hydro-processing and
separation operations
- Process capabilities on a global basis through
Contract Manufacturing Organizations
Amyris Farnesene plant up and running >2.5 yrs; we were able to address one
key aspect for the certification process
TOOK A VILLAGE TO RAISE THIS CHILD
At scale tests confirmed similar performances as with fossil jet fuel
● Successful engines and combustor rig tests
- Snecma SaM 146 and P&W 615F on 10% and 20% blends
- No deviation between blends and reference jet fuel
(performance, operability, emissions, post test inspection)
● Validation of the use of farnesane on Auxiliary Power Unit
- Tests performed by Honeywell on 10 and 20% blends
- Atomization & ignition and APU cold and altitude starting OK
● Lufthansa monitored better emission performances with
farnesane blends on commercial engine
● Successful flight tests with A321 and Etihad B777
- Engine fueled with 10% blend performed “normally”
20 Commercializing Industrial Biotech_Sept. 2015
COMPLETION OF THE ASTM CERTIFICATION IN JUNE 2014
● Formal ASTM
certification is a 2-step
ballot process (>2
months)
- Research report
- Revised ASTM D7566 specifications
● Unanimity is required
to pass (~600 voters
are allowed)
Commercial flights on 10% blend are allowed since June 2014
21 Commercializing Industrial Biotech_Sept. 2015
NEW CHALLENGES: COMMERCIALIZATION AND
PRICE REDUCTION
22 Commercializing Industrial Biotech_Sept. 2015
INDUSTRIAL AND COMMERCIAL OPERATIONS STARTED
● Aviation grade farnesane is produced reliably at
commercial scale
- Amyris facility in Brotas, Brazil with a capacity up to 50
million liters per year
- Successful demonstration of the portability of the process
● Compliance with global industry sustainability standards
- Potential net life cycle GHG emissions: 82% reduction compared to fossil kerosene
- Farnesene plant received the first RSB (Roundtable on sustainable Biomaterials)
certification
Farnesane is available and can be delivered to the wing globally, while
respecting aviation industry standards
● “Lab’line for the future” with Air France
- 1 year long program on Toulouse-Paris route with 1
commercial flight / week (A321 equipped with CFM56
engines)
- Implementation of a stringent monitoring protocol
23 Commercializing Industrial Biotech_Sept. 2015
TRANSITION FROM DEMONSTRATION TO COMMODITY
MARKETS
Developing Markets while reducing the price to be competitive with other
alternatives and also fossil derived Jet Fuel
● Improve competitiveness through innovation and quality on the whole value chain
● In the meantime, define local commercial opportunities for renewable jet fuel market
- Early adopters wishing to help create a market for reduced GHG emission aviation fuels
- Niche markets in specific favorable environment (regional regulated environment, captive fleets)
2015 2020 2025
● Efficiency - Maximum theoretical yield =
- S. cerevisiae native central metabolism + farnesene
synthase
- Assuming no sugar goes to biomass or to
“maintenance”
● Speed - Maximum theoretical productivity =
- Aerobic, oxygen-limited, fed-batch fermentation
process
- O2 delivery
24 Commercializing Industrial Biotech_Sept. 2015
HOW ARE WE MAKING THE FUEL READY FOR MARKET?
● Intensive Total sponsored, co-managed R&D program ongoing at Amyris
to hit targets that will reduce costs at scale
● Additionally we are looking at partnering on lignocellulosic feedstock
valorization technologies to implement when R&D is ready
Caspeta and Nielsen, 2013, Nature Biotech
25 Commercializing Industrial Biotech_Sept. 2015
THANK YOU
26 Commercializing Industrial Biotech_Sept. 2015